A broad exome study of the genetic architecture of asthma reveals novel patient subgroups
Sophia Cameron‐Christie(AstraZeneca (United Kingdom)), Slavé Petrovski(AstraZeneca (United Kingdom)), Michael Hühn(AstraZeneca (Sweden)), Simon Young(AstraZeneca (United Kingdom)), Monica L. Gavala(University of Wisconsin–Madison), Henric Olsson(AstraZeneca (Sweden)), Daniel Muthas(AstraZeneca (Sweden)), Graham Belfield(AstraZeneca (Sweden)), Inken Dillmann(AstraZeneca (Sweden)), Julia Lindgren(AstraZeneca (Sweden)), Quanli Wang, B. Angermann(AstraZeneca (Sweden)), Glenda Lassi(AstraZeneca (United Kingdom)), Adam Platt(AstraZeneca (United Kingdom)), Gundula Povysil(Bridgepoint (United States)), Jingya Wang(Center for Children), E. Suzanne Cohen(AstraZeneca (Switzerland)), Yoichiro Ohne(AstraZeneca (Sweden)), Sri V. V. Deevi(University of Cambridge), Alex Mackay(University of Wollongong)
Cited by 7
Related Papers
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
|Science|2015|980
Unexplored therapeutic opportunities in the human genome
|Nature Reviews Drug Discovery|2018|391